Latest Breaking News On - Hiroyuki sonoda - Page 1 : comparemela.com

JCR Pharmaceuticals : FY2023 Second Half Results Briefing Session Script （2,257KB）

JCR Pharmaceuticals : FY2023 Second Half Results Briefing Session Script （2,257KB）
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesHiroyuki sonodaRyo mizunoAnne bechetShin ashidaYoh itoYoshihiro ohtaFumiyoshi sakaiMorgan stanleyShinya tsuzukiToru ashidaKazuaki hashiguchiShinichiro muraokaHidemaru yamaguchiCo ltdResearch division

JCR Pharmaceuticals : FY2023 Results Briefing Session -Material-（1,196KB）

JCR Pharmaceuticals : FY2023 Results Briefing Session -Material-（1,196KB）
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesHiroyuki sonodaAnne bechetPharmaceuticals co ltdWave of technology innovationResearch divisionBriefing sessionInitiate phaseDevelopmental pipelinesActing officerGeneral managerLatin americaTrack designationPediatric disease designationGlobal phaseOrphan drug designation

JCR Pharmaceuticals : FY2022 Second-Half Results Briefing Session -Script-（6,169KB）

JCR Pharmaceuticals Co., Ltd. Financial Results Briefing for the Fiscal Year Ended March 2023 May 12, 2023 . | May 16, 2023

United statesShinya tsuzukiYoh itoHidemaru yamaguchiToru ashidaHiroyuki matsubaraRyuta kawamuraNaomi kumagaiMathias schmidtYoshihiro ohtaKazuaki hashiguchiMorgan stanleyShin ashidaYutaka hondaHiroyuki sonodaShinichiro muraoka

JCR Pharmaceuticals Receives the WORLDSymposium™ New Treatment Award for IZCARGO® (Pabinafusp Alfa)

JCR Pharmaceuticals Receives the WORLDSymposium™ New Treatment Award for IZCARGO® (Pabinafusp Alfa) - read this article along with other careers information, tips and advice on BioSpace

United statesSan diegoWilliamm pardridgeLos angelesNeuronopathic mucopolysaccharidosisHiroyuki sonodaShin ashidaUniversity of californiaPharmaceuticals co ltdMinistry of healthDrug administrationResearch on lysosomal diseasesEuropean medicines agencyBrazilian health surveillance agency agNew treatment awardFast track